Correlation Between Apellis Pharmaceuticals and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Caribou Biosciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Caribou Biosciences.
Diversification Opportunities for Apellis Pharmaceuticals and Caribou Biosciences
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Apellis and Caribou is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Caribou Biosciences
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.69 times more return on investment than Caribou Biosciences. However, Apellis Pharmaceuticals is 1.45 times less risky than Caribou Biosciences. It trades about -0.01 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.03 per unit of risk. If you would invest 4,545 in Apellis Pharmaceuticals on September 1, 2024 and sell it today you would lose (1,152) from holding Apellis Pharmaceuticals or give up 25.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Caribou Biosciences
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Caribou Biosciences |
Apellis Pharmaceuticals and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Caribou Biosciences
The main advantage of trading using opposite Apellis Pharmaceuticals and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |